Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103


PVALB, a new Hürthle adenoma diagnostic marker identified through gene expression.

Cerutti JM, Oler G, Delcelo R, Gerardt R, Michaluart P Jr, de Souza SJ, Galante PA, Huang P, Riggins GJ.

J Clin Endocrinol Metab. 2011 Jan;96(1):E151-60. doi: 10.1210/jc.2010-1318. Epub 2010 Oct 6.


ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy.

Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A.

Ann Surg. 2005 Sep;242(3):353-61; discussion 361-3.


Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.

Kebebew E, Peng M, Reiff E, McMillan A.

Cancer. 2006 Jun 15;106(12):2592-7.


Expression of cytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reaction.

Flanagan JN, Pineda P, Knapp PE, De Las Morenas A, Lee SL, Braverman LE.

Endocr Pract. 2008 Mar;14(2):168-74.


Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.

Sugishita Y, Kammori M, Yamada O, Yamazaki K, Ito K, Fukumori T, Yoshikawa K, Yamada T.

Ann Surg Oncol. 2014 Jul;21(7):2318-25. doi: 10.1245/s10434-014-3552-6. Epub 2014 Feb 22.


Cyclin D1 and D3 overexpression predicts malignant behavior in thyroid fine-needle aspirates suspicious for Hurthle cell neoplasms.

Troncone G, Volante M, Iaccarino A, Zeppa P, Cozzolino I, Malapelle U, Palmieri EA, Conzo G, Papotti M, Palombini L.

Cancer. 2009 Dec 25;117(6):522-9. doi: 10.1002/cncy.20050.


Identification of genes differentially expressed in benign versus malignant thyroid tumors.

Prasad NB, Somervell H, Tufano RP, Dackiw AP, Marohn MR, Califano JA, Wang Y, Westra WH, Clark DP, Umbricht CB, Libutti SK, Zeiger MA.

Clin Cancer Res. 2008 Jun 1;14(11):3327-37. doi: 10.1158/1078-0432.CCR-07-4495.


MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.

Vriens MR, Weng J, Suh I, Huynh N, Guerrero MA, Shen WT, Duh QY, Clark OH, Kebebew E.

Cancer. 2012 Jul 1;118(13):3426-32. doi: 10.1002/cncr.26587. Epub 2011 Oct 17.


UbcH10 expression on thyroid fine-needle aspirates.

Guerriero E, Ferraro A, Desiderio D, Pallante P, Berlingieri MT, Iaccarino A, Palmieri E, Palombini L, Fusco A, Troncone G.

Cancer Cytopathol. 2010 Jun 25;118(3):157-65. doi: 10.1002/cncy.20046.


Diagnosis of suspicious thyroid nodules using four protein biomarkers.

Cerutti JM, Latini FR, Nakabashi C, Delcelo R, Andrade VP, Amadei MJ, Maciel RM, Hojaij FC, Hollis D, Shoemaker J, Riggins GJ.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3311-8.


ECM1 expression in thyroid tumors--a comparison of real-time RT-PCR and IHC.

Lal G, Padmanabha L, Nicholson R, Smith BJ, Zhang L, Howe JR, Robinson RA, O'Dorisio MS.

J Surg Res. 2008 Sep;149(1):62-8. doi: 10.1016/j.jss.2007.10.014. Epub 2007 Nov 26.


A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.

Cerutti JM, Delcelo R, Amadei MJ, Nakabashi C, Maciel RM, Peterson B, Shoemaker J, Riggins GJ.

J Clin Invest. 2004 Apr;113(8):1234-42.


A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.

Keutgen XM, Filicori F, Crowley MJ, Wang Y, Scognamiglio T, Hoda R, Buitrago D, Cooper D, Zeiger MA, Zarnegar R, Elemento O, Fahey TJ 3rd.

Clin Cancer Res. 2012 Apr 1;18(7):2032-8. doi: 10.1158/1078-0432.CCR-11-2487. Epub 2012 Feb 20.


Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs.

Kitano M, Rahbari R, Patterson EE, Xiong Y, Prasad NB, Wang Y, Zeiger MA, Kebebew E.

Ann Surg Oncol. 2011 Nov;18(12):3443-52. doi: 10.1245/s10434-011-1766-4. Epub 2011 May 7.


Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.

Hoos A, Stojadinovic A, Singh B, Dudas ME, Leung DH, Shaha AR, Shah JP, Brennan MF, Cordon-Cardo C, Ghossein R.

Am J Pathol. 2002 Jan;160(1):175-83.


[Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].

Cerutti JM.

Arq Bras Endocrinol Metabol. 2007 Jul;51(5):832-42. Review. Portuguese.


Intensity and distribution of immunohistochemical expression of galectin-3 in thyroid neoplasms.

Matesa-Anić D, Moslavac S, Matesa N, Cupić H, Kusić Z.

Acta Clin Croat. 2012 Jun;51(2):237-41.


Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.

Liou MJ, Chan EC, Lin JD, Liu FH, Chao TC.

Cancer Lett. 2003 Mar 10;191(2):223-7.


Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid.

Segev DL, Saji M, Phillips GS, Westra WH, Takiyama Y, Piantadosi S, Smallridge RC, Nishiyama RH, Udelsman R, Zeiger MA.

J Clin Endocrinol Metab. 1998 Jun;83(6):2036-42.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk